| Structure | Chemical Name | CAS | MF |
|
D-7-hydroxy-6,8-diiodo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
|
160080-87-5
|
C10H9I2NO3
|
|
CDP-STAR
|
160081-62-9
|
C18H19Cl2Na2O7P
|
|
phospholipase A2 inhibitory protein, Naja naja kaouthia
|
160082-09-7
|
|
|
10-Methyl Docetaxel
|
160084-81-1
|
C44H55NO14
|
|
4-Keto Ibutilide
|
160087-98-9
|
C20H34N2O4S
|
|
5-Isoquinolinamine,1,8-dimethyl-(9CI)
|
160088-26-6
|
C11H12N2
|
|
N-(5-Chloro-4-methoxy-2-nitrophenyl)acetamide
|
160088-53-9
|
C9H9ClN2O4
|
|
5-Chloro-4-methoxy-2-nitroaniline
|
160088-54-0
|
C7H7ClN2O3
|
|
4-(Piperidinocarbonyl)benzonitrile
|
160094-26-8
|
C13H14N2O
|
|
7-((4-NITROPHENYLAMINO)METHYL)QUINOLIN-8-OL
|
160094-85-9
|
C16H13N3O3
|
|
7-(4-CHLOROPHENETHYL)QUINOLIN-8-OL
|
160094-86-0
|
C16H13ClN2O
|
|
7-((2-HYDROXYPHENYLAMINO)METHYL)QUINOLIN-8-OL
|
160094-88-2
|
C16H14N2O2
|
|
7-((2-CHLOROPHENYLAMINO)METHYL)QUINOLIN-8-OL
|
160094-89-3
|
C16H13ClN2O
|
|
1H-Indole, 4-nitro-5-phenyl-
|
160096-30-0
|
C14H10N2O2
|
|
VERATRYLCURCUMINOID
|
160096-59-3
|
C23H24O6
|
|
2,5-Dibromo-3-tetradecylthiophene
|
160096-74-2
|
C18H30Br2S
|
|
2-Bromo-5-iodo-3-hexylthiophene
|
160096-76-4
|
C10H14BrIS
|
|
8,5-DIFERULICACID
|
160097-30-3
|
C20H18O8
|
|
(R)-(+)-Pantoprazole Sodium Salt
|
160098-11-3
|
C16H16F2N3NaO4S
|
|
Cryptofolione
|
160098-78-2
|
C19H22O4
|
|
solorinine
|
160098-90-8
|
C15H23NO5
|
|
Hamacanthine A
|
160098-92-0
|
C20H14Br2N4O
|
|
Hamacanthine B
|
160098-93-1
|
C20H14Br2N4O
|
|
SCH 58261
|
160098-96-4
|
C18H15N7O
|
|
|
Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-hydroxy-, C12-14-alkyl ethers, magnesium salts
|
160104-51-8
|
|
|
|
Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-hydroxy-, C16-18 and C18-unsatd. alkyl ethers, magnesium salts
|
160104-52-9
|
|
|
N4-Benzoyl-5-methylcytidine
|
160107-15-3
|
C17H19N3O6
|
|
N-blocked-5'-O-DMT-2'-O-Fpmp CED cytidine phosphoramidite
|
160107-23-3
|
C58H66FN6O10P
|
|
Benzamide, 3-amino-N-cyano- (9CI)
|
160108-61-2
|
C8H7N3O
|
|
1-(2,2-DIPHENYLETHEN-1-YL)PYRENE
|
160108-81-6
|
C30H20
|
|
N-Fmoc-5-aminolevulinic acid
|
160111-41-1
|
C20H19NO5
|
|
{(E)-3-[(6R,7R)-7-AMINO-2-CARBOXYLATO-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-EN-3-
|
160115-08-2
|
C15H22N4O4S
|
|
2-Acetamido-5-Chloro-6-Picoline
|
160115-16-2
|
C8H9ClN2O
|
|
(S)-(-)-3-BIS(METHOXYCARBONYL)METHYL-1-CYCLOPENTANONE
|
160115-23-1
|
C10H14O5
|
|
07:0 LYSO PC
|
160118-49-0
|
C15H32NO7P
|
|
|
LDLC protein
|
160124-07-2
|
|
|
IAP35 protein
|
160125-03-1
|
C18H19N3O
|
|
TRIPHENYL[2-(1H-TETRAZOL-5-YL)ETHYLPHOSPHONIUM BROMIDE
|
160126-54-5
|
C21H20BrN4P
|
|
1-Azabicyclo[2.2.2]octan-3-ol, 3-ethynyl-, (3S)- (9CI)
|
160127-75-3
|
C9H13NO
|
|
7-Chloro-1,2,3,4-tetrahydrobenzo(b)azepin-5-one
|
160129-45-3
|
C10H10ClNO
|
|
tert-butyl 3-(2-((Methylsulfonyl)oxy)ethyl)pyrrolidine-1-carboxylate
|
160132-53-6
|
C12H23NO5S
|
|
1-Pyrrolidinecarboxylic acid, 3-(2-hydroxyethyl)-, 1,1-dimethylethyl ester
|
160132-54-7
|
C11H21NO3
|
|
Cyclohexanecarboxylic acid, 4-[(2-hydroxyethyl)amino]-, methyl ester, trans- (9CI)
|
160132-89-8
|
C10H19NO3
|
|
4-Methyl-4-phenylpiperidine
|
160132-91-2
|
C12H17N
|
|
4-aminobicyclo[2.2.2]octane-1-carbonitrile hydrochloride
|
160133-27-7
|
C9H15ClN2
|
|
2,2''-(1-BENZYLPIPERIDINE-4,4-DIYL)DIETHANOL
|
160133-33-5
|
C16H25NO2
|
|
4H-Cyclopenta[b]thiophene-2-carboxylicacid,3-amino-5,6-dihydro-,methyl
|
160133-73-3
|
C9H11NO2S
|
|
METHYL 3-AMINO-4-(4-METHYLPHENYL)-THIOPHENE-2-CARBOXYLATE
|
160133-75-5
|
C13H13NO2S
|
|
3-AMINO-4-METHYL-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID METHYL ESTER
|
160133-79-9
|
C13H13NO2S
|
|
2-[(6S)-2,2-dimethyl-7-oxo-6-[(3-phenyl-2-sulfanyl-propanoyl)amino]azepan-1-yl]acetic acid
|
160135-92-2
|
C19H26N2O4S
|
|
Propanal, 3-(2-benzothiazolylthio)- (9CI)
|
160137-19-9
|
C10H9NOS2
|
|
L-744 832
|
160141-09-3
|
C26H45N3O6S2
|
|
(2S,3S)-N-CHLOROACETYL-2-HYDROXYMETHYL-3-METHYLPENTYLAMINE
|
160141-19-5
|
C8H16ClNO2
|
|
(5S)-5-[(1S)-Methylpropyl]-morpholin-3-one
|
160141-20-8
|
C8H15NO2
|
|
4-T-BOC-(5S)-5-[(1S)-METHYLPROPYL]-MORPHOLIN-3-ONE
|
160141-21-9
|
C13H23NO4
|
|
(2S)-[(2'S)-T-BOC-AMINO-(3'S)-METHYL-1-PENTYLOXY]-3-PHENYLPROPIONIC ACID
|
160141-23-1
|
C20H31NO5
|
|
2-(2-Methoxypropan-2-yl)pyrrolidine
|
160142-25-6
|
C8H17NO
|
|
3-De[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-6-O-methyl-3-oxo-erythromycin 2'-acetate
|
160145-82-4
|
C32H53NO10
|
|
Telithromycin intermediate (7A)
|
160145-83-5
|
C36H55N3O11
|
|
4-[(1R,2R)-3-(4-Fluorophenyl)-2-hydroxy-1-(1,2,4-triazol-1-yl)propyl]benzonitrile
|
160146-16-7
|
C18H15FN4O
|
|
Cyclohexanone, 4-(3,4,5-trifluorophenyl)-
|
160148-05-0
|
C12H11F3O
|
|
2-(1,3-benzothiazol-2-yl)-4-chloro-3-oxobutanenitrile
|
160148-12-9
|
C11H7ClN2OS
|
|
1H-Pyrrolo[1,2-a]benzimidazole-3-carbonitrile,2-hydroxy-(9CI)
|
160148-17-4
|
C11H7N3O
|
|
4-(bromomethyl)-2-phenyl-4,5-dihydrooxazole
|
160149-03-1
|
C10H10BrNO
|
|
N-HYDROXY-2,4,6-TRIMETHOXY-BENZAMIDINE
|
160150-34-5
|
C10H14N2O4
|
|
2,4,6-TRIMETHOXY-BENZAMIDINE
|
160150-35-6
|
C10H14N2O3
|
|
1-Cyclohexene-1-carboxaldehyde,4-(1-methylethyl)-3-oxo-(9CI)
|
160152-34-1
|
C10H14O2
|
|
2,4-Oxazolidinedione,5,5-dimethyl-,4-[(1-methylethylidene)hydrazone](9CI)
|
160155-04-4
|
C8H13N3O2
|
|
1H-Pyrrole-2-carboxamide,N-formyl-(9CI)
|
160156-23-0
|
C6H6N2O2
|
|
Fmoc-Lys(biotinyl-e-aminocaproyl)-OH
|
160158-05-4
|
C37H49N5O7S
|
|
BIM-23127
|
160161-61-5
|
C62H73N11O9S2
|
|
juglomycin Z
|
160162-39-0
|
C15H14O6
|
|
SR 11302
|
160162-42-5
|
C26H32O2
|
|
BOC-3-(4'methoxycarbonyl)-L-alanine mesthyl ester
|
160168-19-4
|
C17H23NO6
|
|
FMOC-L-THR(BETA-D-GLCNAC(AC)3)-OH
|
160168-40-1
|
C33H38N2O13
|
|
Cyclohexanone, 2-methyl-5-(1-methylethyl)-, (5S)- (9CI)
|
160168-89-8
|
C10H18O
|
|
(S)-N-[2-(2,6-diMethylphenoxy)-1-Methylethyl]acetaMide
|
160169-32-4
|
C13H19NO2
|
|
[R-(E)]-2-(3-Ethoxy-3-oxo-1-propenyl)-1-piperidinecarboxylic Acid Phenylmethyl Ester
|
160169-47-1
|
C18H23NO4
|
|
Ethyl N-Benzyloxycarbonyl-3-[(2R)-piperidinyl)]-(2R,3S)-dihydroxrpropanoate
|
160169-48-2
|
C18H25NO6
|
|
[1R-(1a,2,8aa)]-Hexahydro-1,2-dihydroxy-3(2H)-indolizinone
|
160169-49-3
|
C8H13NO3
|
|
3,5-dichloro-N-(1-chloro-3-methyl-2-oxo-pentan-3-yl)-4-methyl-benzamide
|
160171-18-6
|
C14H16Cl3NO2
|
|
1-Azabicyclo[2.2.2]octan-3-ol, 3-ethynyl-, (3R)- (9CI)
|
160172-20-3
|
C9H13NO
|
|
Vinyl tris(dimethylsiloxy)silane
|
160172-46-3
|
C8H24O3Si4
|
|
7-propan-2-yl-1,5,7-triazabicyclo[4.4.0]dec-5-ene
|
160172-95-2
|
C10H19N3
|
|
3-Hepten-2-one, 4-ethyl- (9CI)
|
160174-26-5
|
C9H16O
|
|
Granisetron Impurity C
|
160177-67-3
|
C17H22N4O
|
|
triammine(mu-(1,4-butanediamine-N,N'))diamminemonochlorodi-platinum(II)
|
160178-98-3
|
C4H20ClN7Pt2+3
|
|
|
METHACRYL-POSS CAGE MIXTURE
|
160185-24-0
|
|
|
|
S glycoprotein, plant
|
160185-73-9
|
|
|
L-Norvaline, 5-hydroxy-2-methyl- (9CI)
|
160187-05-3
|
C6H13NO3
|
|
1H-Cyclopent[c]isoxazol-6-ol,5-fluorohexahydro-,[3aS-(3aalpha,5alpha,6alpha,6aalpha)]-
|
160189-50-4
|
C6H10FNO2
|
|
Cyclopentanemethanol, 2-amino-4-fluoro-3-hydroxy-, [1S-(1alpha,2alpha,3beta,4beta)]- (9CI)
|
160189-51-5
|
C6H12FNO2
|
|
3-amino-cyclobutanecarboxylic acid
|
160191-58-2
|
C5H9NO2
|
|
(4S,4'S)-2,2'-(Pentane-3,3'-diyl)bis(4-benzyl-4,5-dihydrooxazole)
|
160191-64-0
|
C25H30N2O2
|
|
(4S 4'S)-(-)-2 2'-(3-PENTYLIDENE)BIS(4-&
|
160191-65-1
|
C17H30N2O2
|
|
Cyclohexanone, 3-acetyl-4-methyl-, trans- (9CI)
|
160192-18-7
|
C9H14O2
|
|
2-Pentanone, 3-ethyl-3-(hydroxymethyl)- (9CI)
|
160193-85-1
|
C8H16O2
|
|
3-Iodo-4-aMinobenzotriazole
|
160194-26-3
|
C9H9IN4
|
|
1-TRIETHYLSILYL-4-(TRIETHLYLSILYLOXY)-1-BUTYNE
|
160194-28-5
|
C16H34OSi2
|
|
4-(TRIETHYLSILYL)-3-BUTYN-1-OL
|
160194-29-6
|
C10H20OSi
|